President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...

Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

Medicare spent $14.4 billion on Ozempic ... Ozempic, which the US Food and Drug Administration has approved to treat diabetes, and Wegovy, which is approved for weight loss and the prevention ...

This past year featured key developments in the prescription drug policy area, including the implementation of significant ...

President Donald Trump’s nominee to run the Department of Health and Human Services, Robert F. Kennedy Jr., was in the hot ...